Opportunities are available for companies to join us as Corporate Members. Benefits include a reduction in the exhibition fee at the annual meeting and a number of free registrations for staff to attend. The cost per annum starts at €5,000. If you are interested, please contact Anne Taft at the EVF office (email@example.com) for further information.
Founded in 1912, the medium-sized company Kreussler Pharma is the originator of Aethoxysklerol® (active ingredient Polidocanol) for sclerotherapy of all types of varicose veins. Sold in more than 50 countries, Aethoxysklerol® is widely considered as the world’s leading sclerosing agent. Recent milestones were FDA approval (Asclera®) in the USA and foam approval in several European countries.
For further information on Kreussler Pharma, please visit their website: http://www.aethoxysklerol-international.com